COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06LFE
|
|||
Drug Name |
Indomethacin
|
|||
Synonyms |
indomethacin; 53-86-1; indometacin; Indocin; Indometacine; Indomethacine; Indocid; Metindol; Amuno; Indomethazine; Imbrilon; Tannex; Indomethacinum; Sadoreum; Reumacide; Idomethine; Artrinovo; Mikametan; Methazine; Indoptol; Confortid; Artracin; Metartril; Infrocin; Indoptic; Artrivia; Inflazon; Indomecol; Mobilan; Lausit; Indacin; Dolovin; Indomed; Metacen; Indomee; Inacid; Indo-rectolmin; Indo-tablinen; Inteban sp; Indometacyna; Indometicina; Mezolin; Indo-Lemmon; Indocin Sr; Indometacinum; Indometacina; Indorektal; Durametacin; Indomethine; Elmetacin; D; Indomethacin
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Phase 1/2 | [1] | |
Other Indication | Rheumatoid arthritis | Approved | [2] | |
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H16ClNO4
|
|||
Canonical SMILES |
CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
|
|||
InChI |
1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)
|
|||
InChIKey |
CGIGDMFJXJATDK-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 53-86-1
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:49662
|
References | Top | |||
---|---|---|---|---|
1 | ClinicalTrials.gov (NCT04344457) Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19. U.S. National Institutes of Health. | |||
2 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 090403. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.